Screening of Health Care Workers Before Hepatitis B Vaccination: More Questions than Answers

1985 ◽  
Vol 103 (5) ◽  
pp. 793 ◽  
Author(s):  
ROBERT P. PERRILLO
2021 ◽  
Vol 2 (1) ◽  
pp. 57-62
Author(s):  
A S Obekpa ◽  
A O Malu ◽  
R Bello ◽  
M Duguru

Health care workers are high-risk group for contracting hepatitis B and C virus infections. Hepatitis B and C can be contracted in the hospital setting by needle prick injury, contact with blood (and body fluids) and during invasive medical procedures. This study aims to assess the risk of exposure, the concern or perception of healthcare workers about getting infected (with HBV and/or HCV) from the workplace and the level of HBV vaccination uptake among them. The study was carried out during a capacity building workshop organized for health care workers from all the Local Government Areas in Benue State. A self-administered questionnaire was distributed to 168 participants in attendance, after obtaining verbal consent. One hundred and thirty-eight (138) questionnaires were properly filled and returned, 115 (83.3%) have had needle prick injury, 127 (92%) have had blood spilling on them and 118 (85.5%) have been involved in the management of hepatitis patients. One hundred and nineteen (86.2%) were afraid of contracting hepatitis infection from their place of work, 133 (96.4%) were aware of hepatitis B vaccine for adult, 87 (63%) had received at least one dose of hepatitis B vaccine but only 56 (40.6%) received the complete three doses. Health care workers in Benue State are aware of the risk of contracting viral hepatitis at their workplace and are concerned about this risk. However, the uptake of hepatitis B vaccination among them remains poor.


2013 ◽  
Vol 23 (1) ◽  
pp. 72-77 ◽  
Author(s):  
H.G. Ouédraogo ◽  
S. Kouanda ◽  
S. Tiendrébeogo ◽  
G.A. Konseimbo ◽  
C.E. Yetta ◽  
...  

1988 ◽  
Vol 9 (10) ◽  
pp. 462-464 ◽  
Author(s):  
Michael B. Snyder

The availability of both plasma-derived and recombinant hepatitis B vaccines has given hospitals and other health care institutions the possibility of significantly reducing a major infectious hazard in the workplace. With the increasing use and acceptance of these vaccines, many employees who have a significant blood or body fluid exposure (percutaneous or mucous membrane) have already completed hepatitis B vaccination. Concerns have arisen over the duration of protection of vaccination, as it has been over five years since the introduction of the plasma-derived vaccine.


2020 ◽  
Vol 9 (2) ◽  
pp. 23-27
Author(s):  
Shailendra Shrestha ◽  
Pratap Roy

Background: Health care workers are in high risk of getting infected with hepatitis B virus. A large proportion of them do not receive a 3-dose series of hepatitis B vaccination and have anti hepatitis B surface antibody titer  <10 mIU/ml. Materials and Methods: Health care workers of the hemodialysis unit were included from March 2019 to March 2020 and were interviewed about hepatitis B vaccination status. Serum samples of the participants were analyzed for anti hepatitis B surface antibody titer. Participants with antibody titer of <10mIU/ml were given a 3-dose series of hepatitis B vaccination and antibody titer was again measured 1-2 months after the last dose. Results: Among 30 participants, 19 (63.3%) had 3-dose series of hepatitis B vaccination, and all of them had anti hepatitis B antibody titer of >10 mIU/ml. Remaining 11 participants (36.7%), with either partial (6) or no hepatitis B vaccination (5), had antibody titer of <10mIU/ml. The mean ranks of antibody titer was significantly associated with the hepatitis B vaccination status (P<0.001). All 11 participants with antibody titer of <10 mIU/ml received a 3-dose series of hepatitis B vaccine and all of them achieved antibody titer >10 mIU/ml. Conclusion: Our study shows that a large proportion of health care workers of hemodialysis unit were either partially or not vaccinated with hepatitis B vaccination and were having anti hepatitis B antibody titer of <10 mIU/ml. However, with complete 3-dose series of hepatitis B vaccination all of them achieved a protective antibody titer of ≥10 mIU/ml.


Sign in / Sign up

Export Citation Format

Share Document